Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    February 2021
  1. SHALTIEL T, Zheng S, Siderides C, Gleeson EM, et al
    Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33377.
    PubMed     Abstract available


    September 2020
  2. LI M, Sack JS, Rahma OE, Hodi FS, et al
    Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33165.
    PubMed     Abstract available


    May 2020
  3. LIU Z, Suo C, Mao X, Jiang Y, et al
    Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.
    Cancer. 2020;126:2267-2278.
    PubMed     Abstract available


    April 2019
  4. SHIELS MS, Engels EA, Yanik EL, McGlynn KA, et al
    Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
    Cancer. 2019 Apr 12. doi: 10.1002/cncr.32129.
    PubMed     Abstract available


    April 2018
  5. YI SW, Choi JS, Yi JJ, Lee YH, et al
    Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31406.
    PubMed     Abstract available


  6. KIM NG, Nguyen PP, Dang H, Kumari R, et al
    Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31373.
    PubMed     Abstract available


  7. FANG DM, Stewart SL
    Social-cultural, traditional beliefs, and health system barriers of hepatitis B screening among Hmong Americans: A case study.
    Cancer. 2018;124 Suppl 7:1576-1582.
    PubMed     Abstract available


    February 2018
  8. KANTARJIAN HM, Paul S
    Hepatitis C: When high drug prices preclude patient benefit.
    Cancer. 2018 Feb 27. doi: 10.1002/cncr.31292.
    PubMed    


  9. SORIANO V, Tefferi A
    Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
    Cancer. 2018 Feb 27. doi: 10.1002/cncr.31291.
    PubMed    


    November 2017
  10. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Abstract available


  11. MA GX, Lee MM, Tan Y, Hanlon AL, et al
    Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31134.
    PubMed     Abstract available


    July 2017
  12. STUDAWAY A, Ojha RP, Brinkman TM, Zhang N, et al
    Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30913.
    PubMed     Abstract available


    June 2017
  13. LIN YY, Yu MW, Lin SM, Lee SD, et al
    Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30851.
    PubMed     Abstract available


  14. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Abstract available


    May 2017
  15. HWANG JP, Suarez-Almazor ME, Cantor SB, Barbo A, et al
    Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Cancer. 2017 May 18. doi: 10.1002/cncr.30729.
    PubMed     Abstract available


  16. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Abstract available


    December 2016
  17. MOUKHADDER HM, Halawi R, Cappellini MD, Taher AT, et al
    Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30462.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: